Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-16 Sale |
2021-08-17 4:42 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $56.95 | $142,375 | 809,023 (Indirect Direct) |
View |
2021-08-02 Sale |
2021-08-03 4:26 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
250 | $63.99 | $15,998 | 62,930 (Direct) |
View |
2021-08-02 Sale |
2021-08-03 4:23 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $63.99 | $63,990 | 11,008 (Direct) |
View |
2021-07-21 Sale |
2021-07-22 4:24 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $65 | $65,000 | 51,490 (Direct) |
View |
2021-07-15 Sale |
2021-07-16 6:40 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $62.3 | $62,300 | 52,490 (Direct) |
View |
2021-07-15 Sale |
2021-07-16 6:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $62.3 | $155,750 | 811,523 (Indirect Direct) |
View |
2021-07-14 Sale |
2021-07-15 4:56 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
500 | $64.68 | $32,340 | 63,180 (Direct) |
View |
2021-07-08 Sale |
2021-07-09 3:59 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
250 | $65.68 | $16,420 | 63,680 (Direct) |
View |
2021-07-01 Sale |
2021-07-02 4:01 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $64 | $64,000 | 12,008 (Direct) |
View |
2021-06-24 Sale |
2021-06-25 9:48 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $65.61 | $410,063 | 1,238,586 (Direct) |
View |
2021-06-15 Sale |
2021-06-16 4:33 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $64.83 | $162,075 | 814,023 (Indirect Direct) |
View |
2021-06-15 Sale |
2021-06-16 4:32 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
4,000 | $64.96 | $259,830 | 53,490 (Direct) |
View |
2021-06-11 Sale |
2021-06-15 4:04 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $61.55 | $61,555 | 39,008 (Direct) |
View |
2021-06-14 Sale |
2021-06-15 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
500 | $61.84 | $30,920 | 54,930 (Direct) |
View |
2021-06-10 Sale |
2021-06-11 4:07 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
3,417 | $60 | $205,020 | 26,651 (Direct) |
View |
2021-06-01 Sale |
2021-06-02 4:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $56.4 | $56,400 | 13,008 (Direct) |
View |
2021-05-24 Sale |
2021-05-25 4:01 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $47.4 | $296,250 | 1,244,836 (Direct) |
View |
2021-05-18 Sale |
2021-05-20 4:53 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
162,873 | $52.54 | $8,558,129 | 31,855 (Indirect) |
View |
2021-05-18 Sale |
2021-05-19 4:04 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
2,000 | $55 | $110,000 | 57,490 (Direct) |
View |
2021-05-14 Sale |
2021-05-18 4:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
500 | $45.39 | $22,695 | 55,430 (Direct) |
View |
2021-05-14 Sale |
2021-05-18 4:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $45.39 | $113,475 | 816,523 (Indirect Direct) |
View |
2021-05-03 Sale |
2021-05-04 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $50.73 | $50,730 | 14,008 (Direct) |
View |
2021-05-03 Sale |
2021-05-04 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $50.73 | $30,438 | 55,614 (Direct) |
View |
2021-04-30 Sale |
2021-05-03 5:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $50 | $50,000 | 15,008 (Direct) |
View |
2021-04-23 Sale |
2021-04-26 6:02 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $46.13 | $288,313 | 1,251,086 (Direct) |
View |
2021-04-21 Sale |
2021-04-22 6:17 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $45.76 | $114,400 | 819,023 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-09-10 Exercise |
2021-09-13 4:10 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,894 | $0 | 454,428 (Direct) |
View |
2021-09-10 Exercise |
2021-09-13 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,894 | $14 | 454,428 (Direct) |
View |
2021-09-10 Exercise |
2021-09-13 4:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
954 | $4.31 | 109,193 (Direct) |
View |
2021-09-10 Exercise |
2021-09-13 4:08 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
954 | $0 | 109,193 (Direct) |
View |
2021-08-30 Option Award |
2021-09-01 4:34 pm |
N/A 2031-08-29 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George See Remarks |
29,350 | $0 | 29,350 (Direct) |
View |
2021-08-16 Exercise |
2021-08-17 4:42 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 809,023 (Direct) |
View |
2021-08-16 Exercise |
2021-08-17 4:42 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 809,023 (Direct) |
View |
2021-08-02 Exercise |
2021-08-03 4:23 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $3.76 | 11,008 (Direct) |
View |
2021-08-02 Exercise |
2021-08-03 4:23 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $0 | 11,008 (Direct) |
View |
2021-07-21 Exercise |
2021-07-22 4:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $15.52 | 51,490 (Direct) |
View |
2021-07-21 Exercise |
2021-07-22 4:24 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $0 | 51,490 (Direct) |
View |
2021-07-21 Exercise |
2021-07-22 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
14,410 | $4.31 | 1,844,192 (Direct) |
View |
2021-07-21 Exercise |
2021-07-22 4:04 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
14,410 | $0 | 1,844,192 (Direct) |
View |
2021-07-15 Exercise |
2021-07-16 6:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $15.52 | 52,490 (Direct) |
View |
2021-07-15 Exercise |
2021-07-16 6:40 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $0 | 52,490 (Direct) |
View |
2021-07-15 Exercise |
2021-07-16 6:38 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 811,523 (Direct) |
View |
2021-07-15 Exercise |
2021-07-16 6:38 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 811,523 (Direct) |
View |
2021-07-01 Exercise |
2021-07-02 4:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $3.76 | 12,008 (Direct) |
View |
2021-07-01 Exercise |
2021-07-02 4:01 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $0 | 12,008 (Direct) |
View |
2021-06-28 Exercise |
2021-06-29 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
9,000 | $3.76 | 78,591 (Direct) |
View |
2021-06-28 Exercise |
2021-06-29 4:58 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
9,000 | $0 | 78,591 (Direct) |
View |
2021-06-24 Exercise |
2021-06-25 9:48 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $0 | 1,238,586 (Direct) |
View |
2021-06-24 Exercise |
2021-06-25 9:48 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $2.67 | 1,238,586 (Direct) |
View |
2021-06-21 Exercise |
2021-06-22 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
489 | $4.31 | 109,193 (Direct) |
View |
2021-06-21 Exercise |
2021-06-22 4:02 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
489 | $0 | 109,193 (Direct) |
View |
2021-06-15 Exercise |
2021-06-16 4:33 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 814,023 (Direct) |
View |
2021-06-15 Exercise |
2021-06-16 4:33 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 814,023 (Direct) |
View |
2021-06-15 Exercise |
2021-06-16 4:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
4,000 | $15.52 | 53,490 (Direct) |
View |
2021-06-15 Exercise |
2021-06-16 4:32 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
4,000 | $0 | 53,490 (Direct) |
View |
2021-06-11 Exercise |
2021-06-15 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $3.2 | 39,008 (Direct) |
View |
2021-06-11 Exercise |
2021-06-15 4:04 pm |
N/A 2025-06-02 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $0 | 39,008 (Direct) |
View |
2021-06-08 Exercise |
2021-06-09 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
39,880 | $10.03 | 432,760 (Direct) |
View |
2021-06-08 Exercise |
2021-06-09 4:06 pm |
N/A 2027-10-19 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
39,880 | $0 | 432,760 (Direct) |
View |
2021-06-01 Other |
2021-06-02 4:23 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
47,645 | $0 | 424,114 (Indirect) |
View |
2021-06-01 Exercise |
2021-06-02 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $3.76 | 13,008 (Direct) |
View |
2021-06-01 Exercise |
2021-06-02 4:15 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $0 | 13,008 (Direct) |
View |
2021-05-28 Exercise |
2021-06-01 4:53 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
489 | $4.31 | 109,193 (Direct) |
View |
2021-05-28 Exercise |
2021-06-01 4:53 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
489 | $0 | 109,193 (Direct) |
View |
2021-05-24 Exercise |
2021-05-25 4:01 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $0 | 1,244,836 (Direct) |
View |
2021-05-24 Exercise |
2021-05-25 4:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $2.67 | 1,244,836 (Direct) |
View |
2021-05-18 Exercise |
2021-05-19 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
2,000 | $15.52 | 57,490 (Direct) |
View |
2021-05-18 Exercise |
2021-05-19 4:04 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
2,000 | $0 | 57,490 (Direct) |
View |
2021-05-14 Exercise |
2021-05-18 4:05 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 816,523 (Direct) |
View |
2021-05-14 Exercise |
2021-05-18 4:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 816,523 (Direct) |
View |
2021-05-03 Exercise |
2021-05-04 4:14 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $3.76 | 14,008 (Direct) |
View |
2021-05-03 Exercise |
2021-05-04 4:14 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $0 | 14,008 (Direct) |
View |
2021-04-30 Exercise |
2021-05-03 5:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $3.76 | 15,008 (Direct) |
View |
2021-04-30 Exercise |
2021-05-03 5:40 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
1,000 | $0 | 15,008 (Direct) |
View |
2021-04-28 Exercise |
2021-04-29 5:11 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
4,500 | $0 | 1,251,086 (Direct) |
View |
2021-04-28 Exercise |
2021-04-29 5:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
4,500 | $2.67 | 1,251,086 (Direct) |
View |
2021-04-23 Exercise |
2021-04-26 6:02 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $0 | 1,251,086 (Direct) |
View |
2021-04-23 Exercise |
2021-04-26 6:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $2.67 | 1,251,086 (Direct) |
View |
2021-04-23 Exercise |
2021-04-26 6:00 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
10,000 | $0 | 617,301 (Direct) |
View |
2021-04-23 Exercise |
2021-04-26 6:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
10,000 | $14 | 617,301 (Direct) |
View |
2021-04-22 Exercise |
2021-04-23 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
489 | $4.31 | 109,193 (Direct) |
View |
2021-04-22 Exercise |
2021-04-23 4:02 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
489 | $0 | 109,193 (Direct) |
View |
2021-04-21 Exercise |
2021-04-22 6:17 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 819,023 (Direct) |
View |
2021-04-21 Exercise |
2021-04-22 6:17 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 819,023 (Direct) |
View |
2021-04-16 Exercise |
2021-04-19 7:29 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
50,000 | $0 | 617,301 (Direct) |
View |
2021-04-16 Exercise |
2021-04-19 7:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
50,000 | $14 | 617,301 (Direct) |
View |